eSOMA-DM1, a Maytansinoid-Based Theranostic Small-Molecule Drug Conjugate for Neuroendocrine Tumors

D Chapeau, S Beekman, A Piet, L Li… - Bioconjugate …, 2024 - ACS Publications
Background: The main challenges of conventional chemotherapy lie in its lack of selectivity
and specificity, leading to significant side effects. Using a small-molecule drug conjugate …